Cannabis

Etymology

Main article: Etymology of cannabis

Cannabis is a Scythian word. The ancient Greeks learned of the use of cannabis by observing Scythian funerals, during which cannabis was consumed. In Akkadian, cannabis was known as qunubu (𐎯𐎫𐎠𐎭𐏂). It has been claimed by a few scholars that he word was adopted in to the Hebrew language as qaneh bosem (קָנֶה בֹּשׂם), however there is little real backing for this view, and other plants have been proposed being named that.

Description

Cannabis is an annual, dioecious, flowering herb. The leaves are palmately compound or digitate, with serrate leaflets. The first pair of leaves usually have a single leaflet, the number gradually increasing up to a maximum of about thirteen leaflets per leaf (usually seven or nine), depending on variety and growing conditions. At the top of a flowering plant, this number again diminishes to a single leaflet per leaf. The lower leaf pairs usually occur in an opposite leaf arrangement and the upper leaf pairs in an alternate arrangement on the main stem of a mature plant.

The leaves have a peculiar and diagnostic venation pattern (which varies slightly among varieties) that allows for easy identification of Cannabis leaves from unrelated species with similar leaves. As is common in serrated leaves, each serration has a central vein extending to its tip, but in Cannabis this originates from lower down the central vein of the leaflet, typically opposite to the position of the second notch down. This means that on its way from the midrib of the leaflet to the point of the serration, the vein serving the tip of the serration passes close by the intervening notch. Sometimes the vein will pass tangentially to the notch, but often will pass by at a small distance; when the latter happens a spur vein (or occasionally two) branches off and joins the leaf margin at the deepest point of the notch. Tiny samples of Cannabis also can be identified with precision by microscopic examination of leaf cells and similar features, requiring special equipment and expertise.

Reproduction

All known strains of Cannabis are wind-pollinated and the fruit is an achene. Most strains of Cannabis are short day plants, with the possible exception of C. sativa subsp. sativa var. spontanea (= C. ruderalis), which is commonly described as "auto-flowering" and may be day-neutral.

Cannabis is predominantly dioecious, having imperfect flowers, with staminate "male" and pistillate "female" flowers occurring on separate plants. "At a very early period the Chinese recognized the Cannabis plant as dioecious", and the (c. 3rd century BCE) Erya dictionary defined xi 枲 "male Cannabis" and fu 莩 (or ju 苴) "female Cannabis". Male flowers are normally borne on loose panicles, and female flowers are borne on racemes.

Many monoecious varieties have also been described, in which individual plants bear both male and female flowers. (Although monoecious plants are often referred to as "hermaphrodites", true hermaphrodites – which are less common in Cannabis – bear staminate and pistillate structures together on individual flowers, whereas monoecious plants bear male and female flowers at different locations on the same plant.) Subdioecy (the occurrence of monoecious individuals and dioecious individuals within the same population) is widespread. Many populations have been described as sexually labile.

As a result of intensive selection in cultivation, Cannabis exhibits many sexual phenotypes that can be described in terms of the ratio of female to male flowers occurring in the individual, or typical in the cultivar. Dioecious varieties are preferred for drug production, where the fruits (produced by female flowers) are used. Dioecious varieties are also preferred for textile fiber production, whereas monoecious varieties are preferred for pulp and paper production. It has been suggested that the presence of monoecy can be used to differentiate licit crops of monoecious hemp from illicit drug crops, but sativa strains often produce monoecious individuals, which is possibly as a result of inbreeding.

Sex determination

Cannabis has been described as having one of the most complicated mechanisms of sex determination among the dioecious plants. Many models have been proposed to explain sex determination in Cannabis.

Genetic sex determinitaion

Based on studies of sex reversal in hemp, it was first reported by K. Hirata in 1924 that an XY sex-determination system is present. At the time, the XY system was the only known system of sex determination. The X:A system was first described in Drosophila spp in 1925. Soon thereafter, Schaffner disputed Hirata's interpretation, and published results from his own studies of sex reversal in hemp, concluding that an X:A system was in use and that furthermore sex was strongly influenced by environmental conditions.

Since then, many different types of sex determination systems have been discovered, particularly in plants. Dioecy is relatively uncommon in the plant kingdom, and a very low percentage of dioecious plant species have been determined to use the XY system. In most cases where the XY system is found it is believed to have evolved recently and independently.

Since the 1920s, a number of sex determination models have been proposed for Cannabis. Ainsworth describes sex determination in the genus as using "an X/autosome dosage type".

The question of whether heteromorphic sex chromosomes are indeed present is most conveniently answered if such chromosomes were clearly visible in a karyotype. Cannabis was one of the first plant species to be karyotyped; however, this was in a period when karyotype preparation was primitive by modern standards. Heteromorphic sex chromosomes were reported to occur in staminate individuals of dioecious "Kentucky" hemp, but were not found in pistillate individuals of the same variety. Dioecious "Kentucky" hemp was assumed to use an XY mechanism. Heterosomes were not observed in analyzed individuals of monoecious "Kentucky" hemp, nor in an unidentified German cultivar. These varieties were assumed to have sex chromosome composition XX. According to other researchers, no modern karyotype of Cannabis had been published as of 1996. Proponents of the XY system state that Y chromosome is slightly larger than the X, but difficult to differentiate cytologically.

More recently, Sakamoto and various co-authors have used random amplification of polymorphic DNA (RAPD) to isolate several genetic marker sequences that they name Male-Associated DNA in Cannabis (MADC), and which they interpret as indirect evidence of a male chromosome. Several other research groups have reported identification of male-associated markers using RAPD and amplified fragment length polymorphism. Ainsworth commented on these findings, stating,

A polymerase chain reaction-based method for the detection of female-associated DNA polymorphisms by genotyping has been developed.

Environmental sex determination

Environmental sex determination is known to occur in a variety of species. Many researchers have suggested that sex in Cannabis is determined or strongly influenced by environmental factors.

Inducing sex-reversal (causing the growth of opposite-sex flowers) of Cannabis is agriculturally useful because it allows hybridizing plants of the same genetic sex, producing seeds that are genetically single-sexed, which is in turn useful in the cannabinoid-focused sectors (medical and recreational cannabis) as they use female flowers as raw material. Many sex-reversal agents bear no resemblance to plant hormones and work through unknown mechanisms. For example, masculinization is most commonly induced with a variety of silver compounds, including silver thiosulfate, silver nitrate, and colloidal silver (silver oxide nanoparticle). Other masculinization compounds include aminoethoxyvinylglycine and cobalt chloride. Practical feminizing compounds include ethephon (an ethylene releaser).

Induced sex-reversal does not remove all effects of genetic sex. Induced sex-reversal produces defects such as decreased pollen viability and germinability. Still, enough viable pollens are produced through this method for it to be useful.

File:Hemp plants-cannabis sativa-single 3.JPG|A male hemp plant File:Cannabis indica Selkem.jpg|Dense raceme of female flowers typical of drug-type varieties of Cannabis File:Male Cannabis Lemon Kush (Entire Plant).jpg|Male Lemon Kush cannabis plant (12 foot plant) File:Male Lemon Kush Cannabis Plant.jpg|Male Lemon Kush cannabis Flowers File:Mature cannabs tree in India 02.jpg|Cannabis flower buds File:Alcapulco Gold Young Plant.jpg|A young female Acapulco Gold plant (Mexican x Nepalese). Seed grown plant from seeds obtained from a cannabis seed bank. File:Acapulco Gold Female Plant in Bloom 1.jpg|Acapulco Gold female plant in bloom File:Indoor grown Acapulco Gold in Final Stages of Flowering 1.jpg|Indoor grown Acapulco Gold female plant in final stages of flowering

Chemistry

Cannabis plants produce a large number of chemicals as part of their defense against herbivory. One group of these is called cannabinoids, which induce mental and physical effects when consumed.

Cannabinoids, terpenes, terpenoids, and other compounds are secreted by glandular trichomes that occur most abundantly on the floral calyxes and bracts of female plants. File:Cannabis sativa radix profile.png|Root system side view File:Cannabis sativa radix topview.png|Root system top view File:Cannabis hemp sativa (left) indica (right).png|Micrograph C. sativa (left), C. indica (right)

Genetics

Cannabis, like many organisms, is diploid, having a chromosome complement of 2n=20, although polyploid individuals have been artificially produced. The first genome sequence of Cannabis, which is estimated to be 820 Mb in size, was published in 2011 by a team of Canadian scientists.

Taxonomy

The genus Cannabis was formerly placed in the nettle family (Urticaceae) or mulberry family (Moraceae), and later, along with the genus Humulus (hops), in a separate family, the hemp family (Cannabaceae sensu stricto). Recent phylogenetic studies based on cpDNA restriction site analysis and gene sequencing strongly suggest that the Cannabaceae sensu stricto arose from within the former family Celtidaceae, and that the two families should be merged to form a single monophyletic family, the Cannabaceae sensu lato.

Various types of Cannabis have been described, and variously classified as species, subspecies, or varieties:

• plants cultivated for fiber and seed production, described as low-intoxicant, non-drug, or fiber types.
• plants cultivated for drug production, described as high-intoxicant or drug types.
• escaped, hybridised, or wild forms of either of the above types.

Cannabis plants produce a unique family of terpeno-phenolic compounds called cannabinoids, some of which produce the "high" which may be experienced from consuming marijuana. There are 483 identifiable chemical constituents known to exist in the cannabis plant, and at least 85 different cannabinoids have been isolated from the plant. The two cannabinoids usually produced in greatest abundance are cannabidiol (CBD) and/or Δ9-tetrahydrocannabinol (THC), but only THC is psychoactive. Since the early 1970s, Cannabis plants have been categorized by their chemical phenotype or "chemotype", based on the overall amount of THC produced, and on the ratio of THC to CBD. Although overall cannabinoid production is influenced by environmental factors, the THC/CBD ratio is genetically determined and remains fixed throughout the life of a plant. Non-drug plants produce relatively low levels of THC and high levels of CBD, while drug plants produce high levels of THC and low levels of CBD. When plants of these two chemotypes cross-pollinate, the plants in the first filial (F1) generation have an intermediate chemotype and produce intermediate amounts of CBD and THC. Female plants of this chemotype may produce enough THC to be utilized for drug production.

Whether the drug and non-drug, cultivated and wild types of Cannabis constitute a single, highly variable species, or the genus is polytypic with more than one species, has been a subject of debate for well over two centuries. This is a contentious issue because there is no universally accepted definition of a species. One widely applied criterion for species recognition is that species are "groups of actually or potentially interbreeding natural populations which are reproductively isolated from other such groups." Populations that are physiologically capable of interbreeding, but morphologically or genetically divergent and isolated by geography or ecology, are sometimes considered to be separate species. It remains controversial whether sufficient morphological and genetic divergence occurs within the genus as a result of geographical or ecological isolation to justify recognition of more than one species.

Early classifications

The genus Cannabis was first classified using the "modern" system of taxonomic nomenclature by Carl Linnaeus in 1753, who devised the system still in use for the naming of species. He considered the genus to be monotypic, having just a single species that he named Cannabis sativa L."L." stands for Linnaeus, and indicates the authority who first named the species Linnaeus was familiar with European hemp, which was widely cultivated at the time. This classification was supported by Christiaan Hendrik Persoon (in 1807), Lindley (in 1838) and De Candollee (in 1867). These first classification attempts resulted in a four group division:

• Kif (southern hemp - psychoactive)
• Vulgaris (intermediate - psychoactive and fiber)
• Pedemontana (northern hemp - fiber)
• Chinensis (northern hemp - fiber)

In 1785, evolutionary biologist Jean-Baptiste de Lamarck published a description of a second species of Cannabis, which he named Cannabis indica Lam. Lamarck based his description of the newly named species on morphological aspects (trichomes, leaf shape) and geographic localization of plant specimens collected in India. He described C. indica as having poorer fiber quality than C. sativa, but greater utility as an inebriant. Also, C. indica was considered smaller, by Lamarck. Also, woodier stems, alternate ramifications of the branches, narrow leaflets, and a villous calyx in the female flowers were characteristics noted by the botanist.

In 1843, William O'Shaughnessy, used "Indian hemp (C. indica)" in a work title. The author claimed that this choice wasn't based on a clear distinction between C. sativa and C. indica, but may have been influenced by the choice to use the term "Indian hemp" (linked to the plant's history in India), hence naming the species as indica.

Additional Cannabis species were proposed in the 19th century, including strains from China and Vietnam (Indo-China) assigned the names Cannabis chinensis Delile, and Cannabis gigantea Delile ex Vilmorin. However, many taxonomists found these putative species difficult to distinguish. In the early 20th century, the single-species concept (monotypic classification) was still widely accepted, except in the Soviet Union, where Cannabis continued to be the subject of active taxonomic study. The name Cannabis indica was listed in various Pharmacopoeias, and was widely used to designate Cannabis suitable for the manufacture of medicinal preparations.

20th century

In 1924, Russian botanist D.E. Janichevsky concluded that ruderal Cannabis in central Russia is either a variety of C. sativa or a separate species, and proposed C. sativa L. var. ruderalis Janisch, and Cannabis ruderalis Janisch, as alternative names. and Emboden (1974): C. sativa, C. indica and C. ruderalis.

In 1940, Russian botanists Serebriakova and Sizov proposed a complex poly-species classification in which they also recognized C. sativa and C. indica as separate species. Within C. sativa they recognized two subspecies: C. sativa L. subsp. culta Serebr. (consisting of cultivated plants), and C. sativa L. subsp. spontanea (Vav.) Serebr. (consisting of wild or feral plants). Serebriakova and Sizov split the two C. sativa subspecies into 13 varieties, including four distinct groups within subspecies culta. However, they did not divide C. indica into subspecies or varieties. Zhukovski, in 1950, also proposed a two-species system, but with C. sativa L. and C. ruderalis.

The Small scheme

In the 1970s, the taxonomic classification of Cannabis took on added significance in North America. Laws prohibiting Cannabis in the United States and Canada specifically named products of C. sativa as prohibited materials. Enterprising attorneys for the defense in a few drug busts argued that the seized Cannabis material may not have been C. sativa, and was therefore not prohibited by law. Attorneys on both sides recruited botanists to provide expert testimony. Among those testifying for the prosecution was Dr. Ernest Small, while Dr. Richard E. Schultes and others testified for the defense. The botanists engaged in heated debate (outside of court), and both camps impugned the other's integrity.

In 1976, Canadian botanist Ernest Small and American taxonomist Arthur Cronquist published a taxonomic revision that recognizes a single species of Cannabis with two subspecies (hemp or drug; based on THC and CBD levels) and two varieties in each (domesticated or wild). The framework is thus:

• C. sativa subsp. sativa L., presumably selected for traits that enhance fiber or seed production.
  • C. sativa subsp. sativa var. sativa, domesticated variety.
  • C. sativa subsp. sativa var. spontanea Vav., wild or escaped variety.
• C. sativa subsp. indica (Lam.) Small & Cronq., primarily selected for drug production.
  • C. sativa subsp. indica var. indica, domesticated variety.
  • C. sativa subsp. indica var. kafiristanica (Vav.) Small & Cronq, wild or escaped variety.

This classification was based on several factors including interfertility, chromosome uniformity, chemotype, and numerical analysis of phenotypic characters.

The Schultes scheme

Professors William Emboden, Loran Anderson, and Harvard botanist Richard E. Schultes and coworkers also conducted taxonomic studies of Cannabis in the 1970s, and concluded that stable morphological differences exist that support recognition of at least three species, C. sativa, C. indica, and C. ruderalis. For Schultes, this was a reversal of his previous interpretation that Cannabis is monotypic, with only a single species. According to Schultes' and Anderson's descriptions, C. sativa is tall and laxly branched with relatively narrow leaflets, C. indica is shorter, conical in shape, and has relatively wide leaflets, and C. ruderalis is short, branchless, and grows wild in Central Asia. This taxonomic interpretation was embraced by Cannabis aficionados who commonly distinguish narrow-leafed "sativa" strains from wide-leafed "indica" strains. McPartland's review finds the Schultes taxonomy inconsistent with prior work (protologs) and partly responsible for the popular usage.

Popular usage

The scientific debate regarding taxonomy has had little effect on the terminology in widespread use among cultivators and users of drug-type Cannabis. Cannabis aficionados recognize three distinct types based on such factors as morphology, native range, aroma, and subjective psychoactive characteristics. "Sativa" is the most widespread variety, which is usually tall, laxly branched, and found in warm lowland regions. "Indica" designates shorter, bushier plants adapted to cooler climates and highland environments. "Ruderalis" is the informal name for the short plants that grow wild in Europe and Central Asia. The popular scheme is roughly based on Schultes's framework, with some added emphasis on subjective effects.

"Ruderalis" is a very vague concept in popular taxonomy. It may refer to any plant that exhibits wild-type morphology, early flowering (day-neutral flowering, "autoflowering"), or roughly equal CBD and THC levels.

Continuing research

Molecular analytical techniques developed in the late 20th century are being applied to questions of taxonomic classification. This has resulted in many reclassifications based on evolutionary systematics. Several studies of random amplified polymorphic DNA (RAPD) and other types of genetic markers have been conducted on drug and fiber strains of Cannabis, primarily for plant breeding and forensic purposes. Dutch Cannabis researcher E.P.M. de Meijer and coworkers described some of their RAPD studies as showing an "extremely high" degree of genetic polymorphism between and within populations, suggesting a high degree of potential variation for selection, even in heavily selected hemp cultivars. They also commented that these analyses confirm the continuity of the Cannabis gene pool throughout the studied accessions, and provide further confirmation that the genus consists of a single species, although theirs was not a systematic study per se.

An investigation of genetic, morphological, and chemotaxonomic variation among 157 Cannabis accessions of known geographic origin, including fiber, drug, and feral populations showed cannabinoid variation in Cannabis germplasm. The patterns of cannabinoid variation support recognition of C. sativa and C. indica as separate species, but not C. ruderalis. C. sativa contains fiber and seed landraces, and feral populations, derived from Europe, Central Asia, and Turkey. Narrow-leaflet and wide-leaflet drug accessions, southern and eastern Asian hemp accessions, and feral Himalayan populations were assigned to C. indica. As of 2007, taxonomy web sites continue to list Cannabis as a genus with a single species, whilst listing Cannabis Sativa, Cannabis Indica and Cannabis Ruderalis as subspecies.--

A 2015 analysis of single-nucleotide polymorphisms (SNPs) found a clear divide between the drug/resin and hemp/fiber varieties, lending credence to the botanic (Small's) classification scheme.

A 2020 analysis of SNPs reports five clusters of Cannabis. K1 through K3 form a larger cluster corresponding to folk "indica". K4 corresponds to folk "sativa". K5 is a non-resin (fiber/hemp) cluster.

Translating between schemes

There is currently a great conflict between the different schemes of Cannabis nomenclature due to the split from botanic orthodoxy initiated by many errors of Schultes, which is further modified by folk usage.

Breeders, seed companies, and cultivators of drug type Cannabis often describe the ancestry or gross phenotypic characteristics of cultivars by categorizing them as "pure indica", "mostly indica", "indica/sativa", "mostly sativa", or "pure sativa". These categories are highly arbitrary and borderline meaningless due to the current nomenclatural confusion. For example:

• One "AK-47" hybrid strain has received both "Best Sativa" and "Best Indica" awards.
• According to a 2018 news report from CBC, a laboratory at the University of British Columbia found that Jamaican Lamb's Bread, claimed to be 100% Sativa, was in fact almost 100% indica. This is a result of conflicting concepts of names: the lab's concept of indica refers to the botanic concept of non-psychoactive Cannabis.

Legalization of cannabis in Canada () may help spur private-sector research, especially in terms of diversification of strains. It is also hoped improve classification accuracy for cannabis used recreationally. Legalization coupled with Canadian government (Health Canada) oversight of production and labelling will likely result in more—and more accurate—testing to determine exact strains and content. Furthermore, the rise of craft cannabis growers in Canada should ensure quality, experimentation/research, and diversification of strains among private-sector producers. However, there exists a large discrapency of Cannabis nomenclature even in the research sphere. Simply improving classification techniques will not solve the ambiguity of names until an agreement is reached. For example, the 2015 and 2020 SNP studies mentioned above are both conducted at Canadian universities, but they use opposite nomenclatural concepts: the 2015 study adoptes the botanic terminology while the 2020 study adopts the folk (subject effect) terminology.

Phylogeny

Cannabis likely split from its closest relative, Humulus (hops), during the mid Oligocene, around 27.8 million years ago according to molecular clock estimates. The centre of origin of Cannabis is likely in the northeastern Tibetan Plateau. The pollen of Humulus and Cannabis are very similar and difficult to distinguish. The oldest pollen thought to be from Cannabis is from Ningxia, China, on the boundary between the Tibetan Plateau and the Loess Plateau, dating to the early Miocene, around 19.6 million years ago. Cannabis was widely distributed over Asia by the Late Pleistocene. The oldest known Cannabis in South Asia dates to around 32,000 years ago.

Uses

Cannabis is used for a wide variety of purposes.

History

Main article: History of cannabis

According to genetic and archaeological evidence, cannabis was first domesticated about 12,000 years ago in East Asia during the early Neolithic period. The use of cannabis as a mind-altering drug has been documented by archaeological finds in prehistoric societies in Eurasia and Africa. The oldest written record of cannabis usage is the Greek historian Herodotus's reference to the central Eurasian Scythians taking cannabis steam baths. His Histories () records, "The Scythians, as I said, take some of this hemp-seed [presumably, flowers], and, creeping under the felt coverings, throw it upon the red-hot stones; immediately it smokes, and gives out such a vapour as no Greek vapour-bath can exceed; the Scyths, delighted, shout for joy."

In China, the psychoactive properties of cannabis are described in the Shennong Bencaojing (3rd century AD). Cannabis smoke was inhaled by Daoists, who burned it in incense burners.

In the Middle East, use spread throughout the Islamic empire to North Africa. In 1545, cannabis spread to the western hemisphere where Spaniards imported it to Chile for its use as fiber. In North America, cannabis, in the form of hemp, was grown for use in rope, cloth and paper.

Cannabinol (CBN) was the first compound to be isolated from cannabis extract in the late 1800s. Its structure and chemical synthesis were achieved by 1940, followed by some of the first preclinical research studies to determine the effects of individual cannabis-derived compounds in vivo.

Globally, in 2013, 60,400 kilograms of cannabis were produced legally.

Recreational use

Main article: Cannabis (drug)

Cannabis is a popular recreational drug around the world, only behind alcohol, caffeine, and tobacco. In the U.S. alone, it is believed that over 100 million Americans have tried cannabis, with 25 million Americans having used it within the past year. As a drug it usually comes in the form of dried marijuana, hashish, or various extracts collectively known as hashish oil.

Normal cognition is restored after approximately three hours for larger doses via a smoking pipe, bong or vaporizer. However, if a large amount is taken orally the effects may last much longer. After 24 hours to a few days, minuscule psychoactive effects may be felt, depending on dosage, frequency and tolerance to the drug.

Cannabidiol (CBD), which has no intoxicating effects by itself (although sometimes showing a small stimulant effect, similar to caffeine), is thought to reduce the anxiety-inducing effects of high doses of THC, particularly if administered orally prior to THC exposure.

According to Delphic analysis by British researchers in 2007, cannabis has a lower risk factor for dependence compared to both nicotine and alcohol. However, everyday use of cannabis may be correlated with psychological withdrawal symptoms, such as irritability or insomnia, and susceptibility to a panic attack may increase as levels of THC metabolites rise. Cannabis withdrawal symptoms are typically mild and are not life-threatening. Risk of adverse outcomes from cannabis use may be reduced by implementation of evidence-based education and intervention tools communicated to the public with practical regulation measures.

In 2014 there were an estimated 182.5 million cannabis users worldwide (3.8% of the global population aged 15–64). This percentage did not change significantly between 1998 and 2014.

Medical use

Main article: Medical cannabis

Medical cannabis (or medical marijuana) refers to the use of cannabis and its constituent cannabinoids, in an effort to treat disease or improve symptoms. Cannabis is used to reduce nausea and vomiting during chemotherapy, to improve appetite in people with HIV/AIDS, and to treat chronic pain and muscle spasms. Cannabinoids are under preliminary research for their potential to affect stroke. Evidence is lacking for depression, anxiety, attention deficit hyperactivity disorder, Tourette syndrome, post-traumatic stress disorder, and psychosis. Two extracts of cannabis – dronabinol and nabilone – are approved by the FDA as medications in pill form for treating the side effects of chemotherapy and AIDS.

Short-term use increases both minor and major adverse effects. Concerns including memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by accident.

Industrial use (hemp)

Main article: Cannabis (industrial uses)

The term hemp is used to name the durable soft fiber from the Cannabis plant stem (stalk). Cannabis sativa cultivars are used for fibers due to their long stems; Sativa varieties may grow more than six metres tall. However, hemp can refer to any industrial or foodstuff product that is not intended for use as a drug. Many countries regulate limits for psychoactive compound (THC) concentrations in products labeled as hemp.

Cannabis for industrial uses is valuable in tens of thousands of commercial products, especially as fibre ranging from paper, cordage, construction material and textiles in general, to clothing. Hemp is stronger and longer-lasting than cotton. It also is a useful source of foodstuffs (hemp milk, hemp seed, hemp oil) and biofuels. Hemp has been used by many civilizations, from China to Europe (and later North America) during the last 12,000 years. In modern times novel applications and improvements have been explored with modest commercial success.

In the US, "industrial hemp" is classified by the federal government as cannabis containing no more than 0.3% THC by dry weight. This classification was established in the 2018 Farm Bill and was refined to include hemp-sourced extracts, cannabinoids, and derivatives in the definition of hemp.

Ancient and religious uses

Main article: Cannabis and religion, History of medical cannabis

The cannabis plant has a history of medicinal use dating back thousands of years across many cultures. The Yanghai Tombs, a vast ancient cemetery (54 000 m2) situated in the Turfan district of the Xinjiang Uyghur Autonomous Region in northwest China, have revealed the 2700-year-old grave of a shaman. He is thought to have belonged to the Jushi culture recorded in the area centuries later in the Hanshu, Chap 96B. Near the head and foot of the shaman was a large leather basket and wooden bowl filled with 789g of cannabis, superbly preserved by climatic and burial conditions. An international team demonstrated that this material contained THC. The cannabis was presumably employed by this culture as a medicinal or psychoactive agent, or an aid to divination. This is the oldest documentation of cannabis as a pharmacologically active agent. The earliest evidence of cannabis smoking has been found in the 2,500-year-old tombs of Jirzankal Cemetery in the Pamir Mountains in Western China, where cannabis residue were found in burners with charred pebbles possibly used during funeral rituals.

Settlements which date from c. 2200–1700 BCE in the Bactria and Margiana contained elaborate ritual structures with rooms containing everything needed for making drinks containing extracts from poppy (opium), hemp (cannabis), and ephedra (which contains ephedrine). Although there is no evidence of ephedra being used by steppe tribes, they engaged in cultic use of hemp. Cultic use ranged from Romania to the Yenisei River and had begun by 3rd millennium BC Smoking hemp has been found at Pazyryk.

Cannabis is first referred to in Hindu Vedas between 2000 and 1400 BCE, in the Atharvaveda. By the 10th century CE, it has been suggested that it was referred to by some in India as "food of the gods". Cannabis use eventually became a ritual part of the Hindu festival of Holi. One of the earliest to use this plant in medical purposes was Korakkar, one of the 18 Siddhas. The plant is called Korakkar Mooli in the Tamil language, meaning Korakkar's herb.

In Buddhism, cannabis is generally regarded as an intoxicant and may be a hindrance to development of meditation and clear awareness. In ancient Germanic culture, cannabis was associated with the Norse love goddess, Freya. An anointing oil mentioned in Exodus is, by some translators, said to contain cannabis.

In modern times, the Rastafari movement has embraced cannabis as a sacrament. Elders of the Ethiopian Zion Coptic Church, a religious movement founded in the U.S. in 1975 with no ties to either Ethiopia or the Coptic Church, consider cannabis to be the Eucharist, claiming it as an oral tradition from Ethiopia dating back to the time of Christ. Like the Rastafari, some modern Gnostic Christian sects have asserted that cannabis is the Tree of Life. Other organized religions founded in the 20th century that treat cannabis as a sacrament are the THC Ministry, Cantheism, the Cannabis Assembly and the Church of Cognizance.

Since the 13th century CE, cannabis has been used among Sufis – the mystical interpretation of Islam that exerts strong influence over local Muslim practices in Bangladesh, India, Indonesia, Turkey, and Pakistan. Cannabis preparations are frequently used at Sufi festivals in those countries. Pakistan's Shrine of Lal Shahbaz Qalandar in Sindh province is particularly renowned for the widespread use of cannabis at the shrine's celebrations, especially its annual Urs festival and Thursday evening dhamaal sessions – or meditative dancing sessions.

Notes

References

References

1. (2004). "The Medicinal Uses of Cannabis and Cannabinoids". Pharmaceutical Press.
2. (2010). "Dictionary of Medical Terms". Bloomsbury Publishing.
3. (2007). "Marijuana and the Cannabinoids". Humana Press.
4. (2009). "Cannabinoids in Nature and Medicine". [[Wiley-VCH]].
5. (July 2021). "Large-scale whole-genome resequencing unravels the domestication history of ''Cannabis sativa''". Science Advances.
6. "Classification Report". [[United States Department of Agriculture]].
7. (26 January 2015). "Indica, Sativa, Ruderalis – Did We Get It All Wrong?".
8. "Species of ''Cannabis''".
9. "''Cannabis sativa'' L.". Royal Botanic Gardens, Kew.
10. Erowid. 2006. [http://www.erowid.org/plants/cannabis/cannabis_basics.shtml Cannabis Basics]. {{Webarchive. link. (23 April 2007 . Retrieved on 25 February 2007.)
11. (9 December 2016). "Cannabis and Spirituality: An Explorer's Guide to an Ancient Plant Spirit Ally". Simon and Schuster.
12. (2014). "Seeking the Sacred with Psychoactive Substances: Chemical Paths to Spirituality and to God [2 volumes]". Bloomsbury Publishing.
13. (17 September 2020). "Substance Use Disorders: A Biopsychosocial Perspective". Cambridge University Press.
14. "Leaf Terminology (Part 1)". Waynesword.palomar.edu.
15. (1962). "The Medicinal and Poisonous Plants of Southern and Eastern Africa". E & S Livingstone.
16. (1981). "Marijuana Botany: an advanced study, the propagation and breeding of distinctive Cannabis". Ronin PuPublishing.
17. (1975). "Morphological variation of achenes of ''Cannabis''". Canadian Journal of Botany.
18. (2000). "Boys and Girls Come Out to Play: The Molecular Biology of Dioecious Plants". Annals of Botany.
19. (1997). "Genetics of sex determination in flowering plants". Trends in Plant Science.
20. (1973). "The Origin and Use of ''Cannabis'' in Eastern Asia: Linguistic-Cultural Implications". Economic Botany.
21. 13/99 and 13/133. In addition, 13/98 defined ''fen'' 蕡 "''Cannabis'' inflorescence" and 13/159 ''bo'' 薜 "wild ''Cannabis''".
22. Bouquet, R. J. 1950. [https://web.archive.org/web/20071111115805/http://www.unodc.org/unodc/bulletin/bulletin_1950-01-01_4_page003.html ''Cannabis'']. [[United Nations Office on Drugs and Crime]]. Retrieved on 23 February 2007
23. (1999). "Advances in Hemp Research". Haworth Press.
24. (2004). "The sexual differentiation of Cannabis sativa L.: A morphological and molecular study". Euphytica.
25. (1 December 1999). "Cannabis as a licit crop: recent developments in Europe". Global Hemp.
26. (1999). "Preliminary results of a German field trial with different hemp (Cannabis sativa L.) accessions". Genetic Resources and Crop Evolution.
27. (2004). "Current status and future scenarios of hemp breeding". Euphytica.
28. (1924). "Sex reversal in hemp". Journal of the Society of Agriculture and Forestry.
29. (1931). "The Fluctuation Curve of Sex Reversal in Staminate Hemp Plants Induced by Photoperiodicity". American Journal of Botany.
30. (2002). "Biochemical differences in Cannabis sativa L. depending on sexual phenotype". Journal of Applied Genetics.
31. (1925). "Sex in Relation to Chromosomes and Genes". The American Naturalist.
32. (1929). "Heredity and sex". Ohio Journal of Science.
33. (December 2001). "Dioecious plants. A key to the early events of sex chromosome evolution". Plant Physiology.
34. (1964). "Meiotic Chromosomes of Monoecious Kentucky Hemp (Cannabis sativa)". Bulletin of the Torrey Botanical Club.
35. (1996). "Taxonomic studies of Cannabis in China". Journal of the International Hemp Association.
36. (June 2003). "Sex-linked AFLP markers indicate a pseudoautosomal region in hemp ( Cannabis sativa L.)". Theoretical and Applied Genetics.
37. (December 1995). "A male-associated DNA sequence in a dioecious plant, Cannabis sativa L". Plant & Cell Physiology.
38. (October 2005). "RAPD markers encoding retrotransposable elements are linked to the male sex in Cannabis sativa L". Genome.
39. (2002). "Novel male-specific molecular markers (MADC5, MADC6) in hemp". Euphytica.
40. (2003). "Female-Associated DNA Polymorphisms of Hemp (Cannabis sativaL.)". Journal of Industrial Hemp.
41. (2004). "Sex-determining mechanisms in land plants". The Plant Cell.
42. (2021). "Production of Feminized Seeds of High CBD Cannabis sativa L. by Manipulation of Sex Expression and Its Application to Breeding.". Frontiers in Plant Science.
43. (December 1982). "Induction of fertile male flowers in genetically female Cannabis sativa plants by silver nitrate and silver thiosulphate anionic complex". Theoretical and Applied Genetics.
44. M., Linda. (2024-08-03). "Buy Acapulco Gold Feminized Seeds".
45. (2001). "THC (tetrahyrdocannabinol) accumulation in glands of ''Cannabis'' (Cannabaceae)". The Hemp Report.
46. (1972). "Interfertility and chromosomal uniformity in ''Cannabis''". Canadian Journal of Botany.
47. (October 2011). "The draft genome and transcriptome of Cannabis sativa". Genome Biology.
48. (2001). "Plants of the Gods". Healing Arts Press.
49. (2001). "Further evidence for paraphyly of the Celtidaceae from the chloroplast gene mat K". Plant Systematics and Evolution.
50. (September 2002). "Urticalean rosids: circumscription, rosid ancestry, and phylogenetics based on rbcL, trnL-F, and ndhF sequences". American Journal of Botany.
51. (1975). "American law and the species problem in Cannabis: science and semantics". Bulletin on Narcotics.
52. (2009). "What chemicals are in marijuana and its byproducts?". ProCon.org.
53. (June 2010). "Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L". Pharmacology, Biochemistry, and Behavior.
54. (2009). "The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function". Pharmacology.
55. (June 1973). "Common cannabinoid phenotypes in 350 stocks of Cannabis". Lloydia.
56. (January 2003). "The inheritance of chemical phenotype in Cannabis sativa L". Genetics.
57. (June 2004). "A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae)". American Journal of Botany.
58. (1979). "The Species Problem in Cannabis". Science. Corpus Information Services.
59. (1991). "Glossary of Genetics". Springer-Verlag.
60. (2005). "Genetic evidence for speciation in Cannabis (Cannabaceae)". Genetic Resources and Crop Evolution.
61. (1975). "On toadstool soup and legal species of marihuana". Plant Science Bulletin.
62. (1981). "The genus Cannabis and the correct use of taxonomic categories". Journal of Psychoactive Drugs.
63. (1980). "Botany and Chemistry of Hallucinogens". C. C. Thomas.
64. (1957–1959). "Species Plantarum". Ray SocietyLondon, U.K. (originally Salvius, Stockholm).
65. (2023-08-01). "Genomics-based taxonomy to clarify cannabis classification". Genome.
66. (1785). "Encyclopédie Méthodique de Botanique".
67. (1976). "A Practical and Natural Taxonomy for Cannabis". Taxon.
68. (1977). "Some historical aspects of marijuana". Clinical Toxicology.
69. (1975-12-31). "Cannabis: An Example of Taxonomic Neglect". De Gruyter Mouton.
70. Emboden, William A.. (1974). "Cannabis — a polytypic genus". Economic Botany.
71. (1940). "Kulturnaya Flora SSSR".
72. (2020). "Controversial taxonomy of hemp". Genetika.
73. Zhukovskii, P.M. (1971) ''Cultivated plants and their wild relatives''. 3rd ed. Leningrad, USSR, Kolos.
74. (January 2006). "Cannabis confusions". BMJ.
75. [http://pubs.nrc-cnrc.gc.ca/cgi-bin/rp/rp2_gene_e?mlist-authors-small_e.html Ernest Small (biography)] {{webarchive. link. (11 February 2007 . National Research Council Canada. Retrieved on 23 February 2007)
76. (1974). "''Cannabis'': an example of taxonomic neglect". Harvard University Botanical Museum Leaflets.
77. [http://www.bio.fsu.edu/faculty-anderson.php Anderson, L. C.] {{Webarchive. link. (8 March 2009 1974. A study of systematic wood anatomy in ''Cannabis''. ''Harvard University Botanical Museum Leaflets'' '''24''': 29–36. Retrieved on 23 February 2007)
78. [http://www.bio.fsu.edu/faculty-anderson.php Anderson, L. C.] {{Webarchive. link. (8 March 2009 1980. Leaf variation among ''Cannabis'' species from a controlled garden. ''Harvard University Botanical Museum Leaflets'' '''28''': 61–69. Retrieved on 23 February 2007)
79. (1974). "Cannabis — a polytypic genus". Economic Botany.
80. (1970). "The Botany and Chemistry of Cannabis". J. & A. Churchill.
81. [https://web.archive.org/web/20110727002712/http://www.norml.org.nz/modules.php?name=News&file=print&sid=588 Interview with Robert Connell Clarke]. 1 January 2005. NORML, New Zealand. Retrieved on 19 February 2007
82. (1999). "Identification of DNA markers linked to the male sex in dioecious hemp (Cannabis sativa L.)". Theoretical and Applied Genetics.
83. (2001). "Comparison of Hemp Varieties Using Random Amplified Polymorphic DNA Markers". Crop Science.
84. (2002). "The Applications of Molecular Markers in Genetics and Breeding of Hemp". Journal of Industrial Hemp.
85. (January 2003). "Short tandem repeat (STR) DNA markers are hypervariable and informative in Cannabis sativa: implications for forensic investigations". Forensic Science International.
86. (January 2002). "DNA fingerprinting of Cannabis sativa using inter-simple sequence repeat (ISSR) amplification". Planta Medica.
87. (2004). "A chemotaxonomic analysis of terpenoid variation in Cannabis". Biochemical Systematics and Ecology.
88. USDA, ARS, National Genetic Resources Program. [http://www.ars-grin.gov/cgi-bin/npgs/html/splist.pl?2034 Germplasm Resources Information Network (GRIN)], National Germplasm Resources Laboratory, Beltsville, Maryland. Retrieved on 23 February 2007
89. Barlow, Snow. 2006. [http://www.plantnames.unimelb.edu.au/Sorting/Cannabis.html Sorting ''Cannabis'' names]. Multilingual Multiscript Plant Name Database. The University of Melbourne. Retrieved on 23 February 2007
90. [https://www.itis.gov/servlet/SingleRpt/SingleRpt?search_topic=TSN&search_value=19109 Integrated Taxonomic Information System (ITIS)]. Retrieved on 23 February 2007
91. [http://www.taxonomy.nl/Taxonomicon/TaxonTree.aspx?id=6455 The Taxonomicon]. Universal Taxonomic Services. Retrieved on 23 February 2007
92. (2015). "The Genetic Structure of Marijuana and Hemp.". PLOS ONE.
93. (September 2020). "A single nucleotide polymorphism assay sheds light on the extent and distribution of genetic diversity, population structure and functional basis of key traits in cultivated north American cannabis". Journal of Cannabis Research.
94. (2018). "''Cannabis'' Systematics at the Levels of Family, Genus, and Species". Cannabis and Cannabinoid Research.
95. (17 January 2018). "What's in your weed: Why cannabis strains don't all live up to their billing". CBC.
96. . (). ["Will Craft Cannabis Growers in Canada Succeed Like Craft Brewers?"](https://licensedproducerscanada.ca/faq/will-craft-cannabis-growers-in-canada-succeed-like-craft-brewers).
97. (2019-05-14). "Cannabis in Asia: its center of origin and early cultivation, based on a synthesis of subfossil pollen and archaeobotanical studies". Vegetation History and Archaeobotany.
98. (1980). "Marijuana, The First 12,000 years". Plenum Press.
99. (June 2002). "The Medical Use of Cannabis Among the Greeks and Romans". Journal of Cannabis Therapeutics.
100. Herodotus. (1994–2009). "The History of Herodotus". Daniel C. Stevenson, Web Atomics.
101. (2005). "The Cultural History of Plants". Routledge.
102. "Cannabis: History".
103. (1994). "Hemp : lifeline to the future: the unexpected answer for our environmental and economic recovery". Creative Xpressions Publications.
104. (1992). "Hemp & the marijuana conspiracy: the emperor wears no clothes". Hemp Pub.
105. (1992). "Psychedelics Encyclopedia". Ronin Publications.
106. Pertwee, Roger G. (2006). "Cannabinoid pharmacology: the first 66 years: Cannabinoid pharmacology". British Journal of Pharmacology.
107. (2015). "Narcotic Drugs 2014". International Narcotics Control Board.
108. "Drug Toxicity". Web.cgu.edu.
109. "Introduction". NORML.
110. Cannabis. "Erowid Cannabis (Marijuana) Vault: Effects". Erowid.org.
111. (February 1998). "Sedative, stimulant, and other subjective effects of marijuana: relationships to smoking techniques". Pharmacology, Biochemistry, and Behavior.
112. (1982). "Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects". Psychopharmacology.
113. (January 2009). "Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing". Archives of General Psychiatry.
114. (March 2007). "Development of a rational scale to assess the harm of drugs of potential misuse". Lancet.
115. "Marijuana Detection Times Influenced By Stress, Dieting". NORML.
116. "Cannabis use and panic disorder". Cannabis.net.
117. "Myths and Facts About Marijuana". Drugpolicy.org.
118. (August 2017). "Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations". American Journal of Public Health.
119. United Nations Office on Drugs and Crime. (May 2016). "World Drug Report 2016".
120. (February 2013). "The pharmacologic and clinical effects of medical cannabis". Pharmacotherapy.
121. (23 June 2015). "Cannabinoids for Medical Use: A Systematic Review and Meta-analysis". JAMA.
122. (March 2015). "Cannabinoids in experimental stroke: a systematic review and meta-analysis". Journal of Cerebral Blood Flow and Metabolism.
123. (December 2019). "Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis". The Lancet. Psychiatry.
124. (1 July 2020). "Is marijuana safe and effective as medicine?". US National Institute on Drug Abuse.
125. (June 2008). "Adverse effects of medical cannabinoids: a systematic review". CMAJ.
126. "Hemp Facts". Naihc.org.
127. (2017-04-15). "Life cycle assessment of natural building materials: the role of carbonation, mixture components and transport in the environmental impacts of hempcrete blocks". Journal of Cleaner Production.
128. Environmental Professionals Network. (2014-10-08). "The Prospects of Hemp Building Materials".
129. "The cultivation and use of hemp in ancient China". Hempfood.com.
130. (1994). "Hemp Pulp and Paper Production". Journal of the International Hemp Association.
131. (2011). "Industrial Hemp Production in Alberta". Government of Alberta, Agriculture and Rural Development.
132. "7 U.S. Code § 5940 – Legitimacy of industrial hemp research".
133. (April 2006). "Cannabinoids in medicine: A review of their therapeutic potential". Journal of Ethnopharmacology.
134. (1979). "China in Central Asia: The Early Stage 125 BC – AD 23: an annotated translation of chapters 61 and 96 of the History of the Former Han Dynasty". E. J. Brill.
135. (2008). "Phytochemical and genetic analyses of ancient cannabis from Central Asia". Journal of Experimental Botany.
136. (June 2019). "The origins of cannabis smoking: Chemical residue evidence from the first millennium BCE in the Pamirs". Science Advances.
137. (14 June 2019). "Earliest evidence for cannabis smoking discovered in ancient tombs". National Geographic.
138. (2000). "The Tarim Mummies: Ancient China and the Mystery of the Earliest Peoples from the West". Thames & Hudson.
139. (1980). "Marijuana – The First Twelve Thousand Years".
140. (1 January 1865). "Classified Catalogue of Tamil Printed Books: With Introductory Notices". Christian vernacular education society.
141. (5 July 2012). "Parkinson's Disease Dravidian Cure Chintarmony System". Lulu.com.
142. (1 August 2016). "History of Medical and Spiritual Sciences of Siddhas of Tamil Nadu". Notion Press.
143. (1 January 1904). "A Primer of Tamil Literature". Ananda Press.
144. (2005). "Spliffs 3: The Last Word in Cannabis Culture?". Collins & Brown Publishers.
145. "The History of Hemp in Norway". International Hemp Association.
146. (1981). "The Living Torah".
147. (1982). "Dread, The Rastafarians of Jamaica". Heinemann.
148. The Ethiopian Zion Coptic Church. "Marijuana and the Bible". Schaffer Library of Drug Policy.
149. "Zion Light Ministry".
150. (1938). "Green Gold: the Tree of LifeMarijuana in Magic & Religion". Access Unlimited.
151. "The Hawaiʻi Cannabis Ministry".
152. "Cantheism".
153. "Cannabis Assembly".
154. (20 Oct 2016). "Sacred Bliss: A Spiritual History of Cannabis". Rowman & Littlefield.
155. (1979). "A Comprehensive Guide to Cannabis Literature". Greenwood Press.
156. (17 February 2017). "Music, Dancing, And Tolerance -- Pakistan's Embattled Sufi Minority".
157. (2013). "Islamic Reform in South Asia". Cambridge University Press.